IP Library › Granted Patent US 11,366,114
Granted Patent B2
US 11,366,114 · App. 15/033,147 · Granted Jun 21, 2022

Genetically encoded fluorescent sensors for detecting ligand bias and intracellular signaling through cAMP pathways

Inventors: Thomas E. Hughes (Bozeman, MT); Paul H. Tewson (Bozeman, MT); Anne Marie Quinn (Bozemen, MT)
Assignee: Montana Molecular LLC
G01N33/566C07K14/00G01N33/542G01N33/582C07K2319/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,366,114
App. No.
15/033,147
Granted
Jun 21, 2022
Kind
B2
Abstract

Described herein are novel fluorescent sensors for cyclic adenosine monophosphate (cAMP) that are based on single fluorescent proteins. These sensors use less visible spectrum than FRET-based sensors, produce robust changes in fluorescence, and can be combined with one another, or with other sensors, in a multiplex assay on standard fluorescent plate readers or live cell imaging systems.

Claims (17)

1. A nucleic acid molecule encoding a cyclic adenosine monophosphate (cAMP) sensor protein comprising a first polypeptide linked to a second polypeptide, wherein the first polypeptide comprises an amino acid sequence at least 95% identical to amino acids 1-292 of SEQ ID NO: 6; and

the second polypeptide comprises a circularly permuted, fluorescent protein, wherein the fluorescent protein is selected from the group consisting of GFP, eGFP, eYFP, Emerald, mApple, mPlum, mCherry, tdTomato, mStrawberry, J-Red, DsRed-monomer, mOrange, MKO, mCitrine, Venus, YPet, CyPet, mCFPm, Cerulean, T-Sapphire, mKOK, mUKG, Clover, mKate, tagRFP, tagGFP, and mNEON green,

wherein binding of cAMP to the first polypeptide alters the level of fluorescence from the second polypeptide, wherein the C-terminal amino acid of the amino acid sequence at least 95% identical to amino acids 1-292 of SEQ ID NO: 6 is covalently bound to a linker of 1-10 amino acids, and wherein the C-terminal amino acid of the linker is covalently bound to the N-terminal amino acid of the circularly permuted, fluorescent protein.

2. A method of detecting changes in the intracellular level of cAMP, comprising:

a. introducing into a cell a nucleic acid molecule encoding a cAMP sensor protein comprising a first polypeptide linked to a second polypeptide, wherein the first polypeptide comprises an amino acid sequence at least 95% identical to amino acids 1-292 of SEQ ID NO: 6; and the second polypeptide comprises a circularly permuted, fluorescent protein, wherein the fluorescent protein is selected from the group consisting of GFP, eGFP, eYFP, Emerald, mApple, mPlum, mCherry, tdTomato, mStrawberry, J-Red, DsRed-monomer, mOrange, MKO, mCitrine, Venus, YPet, CyPet, mCFPm, Cerulean, T-Sapphire, mKOK, mUKG, Clover, mKate, tagRFP, tagGFP, and mNEON green,

wherein binding of cAMP to the first polypeptide alters the level of fluorescence from the second polypeptide, wherein the C-terminal amino acid of the amino acid sequence at least 95% identical to amino acids 1-292 of SEQ ID NO: 6 is covalently bound to a linker of 1-10 amino acids, and wherein the C-terminal amino acid of the linker is covalently bound to the N-terminal amino acid of the circularly permuted, fluorescent protein; and

b. detecting changes in the intracellular level of fluorescence produced by the fluorescent protein.

3. The nucleic acid molecule of claim 1 , wherein the first polypeptide comprises an amino acid sequence at least 90% identical to the amino acid sequence of SEQ ID NO:37.

4. The method of claim 2 , wherein the first polypeptide comprises an amino acid sequence at least 90% identical to the amino acid sequence of SEQ ID NO:37.

5. The nucleic acid molecule of claim 1 , wherein the first polypeptide comprises an amino acid sequence at least 99% identical to amino acids 1-292 of SEQ ID NO: 6.

6. The nucleic acid molecule of claim 1 , wherein the first polypeptide comprises amino acids 1-292 of SEQ ID NO: 6.

7. The nucleic acid molecule of claim 1 , wherein the second polypeptide comprises mNEON green.

8. The nucleic acid molecule of claim 5 , wherein the second polypeptide comprises mNEON green.

9. The method of claim 2 , wherein the first polypeptide comprises an amino acid sequence at least 99% identical to amino acids 1-292 of SEQ ID NO: 6.

10. The method of claim 2 , wherein the first polypeptide comprises amino acids 1-292 of SEQ ID NO: 6.

11. The method of claim 2 , wherein the second polypeptide comprises mNEON green.

12. The method of claim 9 , wherein the second polypeptide comprises mNEON green.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2017
From: HUGHES, THOMAS E.; TEWSON, PAUL H.; QUINN, ANNE MARIE
To: MONTANA MOLECULAR LLC
Reel/Frame 041477/0272 →
Continuity (2)
Provisional Application 61899611 · Nov 4, 2013
Related Publication 20160274109A1 · Sep 22, 2016